The continuing search for proper perspective: whose reasonableness should be at issue in a prescription product design defect analysis?
This Article is based on a presentation given at Seton Hall University School of Law's Seventh Annual Health Law Symposium on February 12, 1999.
Cupp
R L
RL
Pepperdine University School of Law, USA.
D003226:Congresses as Topic; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence*; D003657:Decision Making; D015195:Drug Design; D011307:Drug Prescriptions; D006801:Humans; D007880:Legislation, Drug; D008091:Literature; D009515:New Jersey; D004364:Pharmaceutical Preparations; D014481:United States
D004364:Pharmaceutical Preparations